Structures by: Pidcock E.
Total: 146
S-4-Sulfo-L-Phenylalanine monohydrate
C9H13N1O6S1
Acta Crystallographica Section B (2009) 65, 6 731-748
a=9.7046(5)Å b=8.1477(3)Å c=12.3071(13)Å
α=90° β=112.034(6)° γ=90°
S-4-Sulfo-L-Phenylalanine monohydrate
C9H13N1O6S1
Acta Crystallographica Section B (2009) 65, 6 731-748
a=9.6213(11)Å b=8.1290(8)Å c=12.298(3)Å
α=90° β=112.049(13)° γ=90°
S-4-Sulfo-L-Phenylalanine monohydrate
C9H13N1O6S1
Acta Crystallographica Section B (2009) 65, 6 731-748
a=9.5437(17)Å b=8.1824(12)Å c=12.151(4)Å
α=90° β=111.30(2)° γ=90°
Bianthrone
C28H16O2
Acta Crystallographica Section B (2011) 67, 3 226-237
a=10.1860(3)Å b=8.4277(2)Å c=11.6457(3)Å
α=90° β=109.591(2)° γ=90°
Bianthrone
C28H16O2
Acta Crystallographica Section B (2011) 67, 3 226-237
a=9.9825(11)Å b=7.8892(15)Å c=11.4879(9)Å
α=90° β=109.780(6)° γ=90°
Bianthrone
C28H16O2
Acta Crystallographica Section B (2011) 67, 3 226-237
a=9.9021(14)Å b=7.6543(18)Å c=11.4225(11)Å
α=90° β=109.860(9)° γ=90°
Bianthrone
C28H16O2
Acta Crystallographica Section B (2011) 67, 3 226-237
a=9.8354(13)Å b=7.4567(19)Å c=11.3543(12)Å
α=90° β=109.939(8)° γ=90°
Bianthrone
C28H16O2
Acta Crystallographica Section B (2011) 67, 3 226-237
a=9.7854(7)Å b=7.2988(11)Å c=11.3074(7)Å
α=90° β=110.028(4)° γ=90°
Bianthrone
C28H16O2
Acta Crystallographica Section B (2011) 67, 3 226-237
a=9.7527(9)Å b=7.2058(15)Å c=11.2786(9)Å
α=90° β=110.132(6)° γ=90°
Bianthrone
C28H16O2
Acta Crystallographica Section B (2011) 67, 3 226-237
a=9.7286(10)Å b=7.1123(17)Å c=11.2468(11)Å
α=90° β=110.186(7)° γ=90°
Salicylaldoxime
C7H7N1O2
Acta Crystallographica Section B (2006) 62, 6 1099-1111
a=10.346(4)Å b=5.0294(17)Å c=13.478(5)Å
α=90° β=112.21(2)° γ=90°
Salicylaldoxime
C7H7N1O2
Acta Crystallographica Section B (2006) 62, 6 1099-1111
a=10.1833(16)Å b=4.9766(3)Å c=13.0109(15)Å
α=90° β=111.938(10)° γ=90°
Salicylaldoxime
C7H7N1O2
Acta Crystallographica Section B (2006) 62, 6 1099-1111
a=9.851(3)Å b=4.9325(7)Å c=12.286(3)Å
α=90° β=111.09(2)° γ=90°
Salicylaldoxime
C7H7N1O2
Acta Crystallographica Section B (2006) 62, 6 1099-1111
a=9.7148(16)Å b=4.9322(3)Å c=12.0145(16)Å
α=90° β=110.607(11)° γ=90°
Salicylaldoxime
C7H7N1O2
Acta Crystallographica Section B (2006) 62, 6 1099-1111
a=9.513(2)Å b=4.9319(4)Å c=11.630(2)Å
α=90° β=109.859(14)° γ=90°
Salicylaldoxime
C7H7N1O2
Acta Crystallographica Section B (2006) 62, 6 1099-1111
a=7.677(3)Å b=5.7731(8)Å c=12.159(3)Å
α=90° β=110.62(2)° γ=90°
3-Hydroxysalicylaldoxime
C7H7N1O3
Acta Crystallographica Section E (2007) 63, 7 o3131-o3131
a=13.4603(10)Å b=3.7507(3)Å c=14.8398(11)Å
α=90° β=114.531(5)° γ=90°
3-fluorosalicylaldoxime
C7H6F1N1O2
Acta Crystallographica Section E (2007) 63, 7 o3132-o3132
a=7.0497(3)Å b=10.5161(4)Å c=9.1022(4)Å
α=90° β=90° γ=90°
Salicylaldoxime
C7H7N1O2
Acta Crystallographica Section E (2006) 62, 9 o3944-o3946
a=7.6691(2)Å b=12.7162(3)Å c=13.3652(3)Å
α=90° β=90° γ=90°
3-Fluorosalicylaldoxime
C7H6F1N1O2
Acta Crystallographica Section E (2009) 65, 8 o2001
a=6.156(2)Å b=9.751(3)Å c=8.6764(18)Å
α=90° β=90° γ=90°
3-aza-bicyclo(3.3.1)nonane-2,4-dione
C8H11N1O2
Crystal Growth & Design (2008) 8, 2 549
a=8.564(7)Å b=10.0876(18)Å c=7.6419(12)Å
α=90° β=96.38(3)° γ=90°
3-aza-bicyclo(3.3.1)nonane-2,4-dione
C8H11N1O2
Crystal Growth & Design (2008) 8, 2 549
a=9.3214(11)Å b=10.5932(12)Å c=7.6988(9)Å
α=90° β=95.059(8)° γ=90°
3-aza-bicyclo(3.3.1)nonane-2,4-dione
C8H11N1O2
Crystal Growth & Design (2008) 8, 2 549
a=8.868(9)Å b=10.2833(16)Å c=7.7016(13)Å
α=90° β=95.88(3)° γ=90°
3-aza-bicyclo(3.3.1)nonane-2,4-dione
C8H11N1O2
Crystal Growth & Design (2008) 8, 2 549
a=8.367(8)Å b=9.9317(17)Å c=7.5667(12)Å
α=90° β=96.49(3)° γ=90°
3-aza-bicyclo(3.3.1)nonane-2,4-dione
C8H11N1O2
Crystal Growth & Design (2008) 8, 2 549
a=8.254(4)Å b=9.8542(15)Å c=7.5245(11)Å
α=90° β=96.63(3)° γ=90°
3-aza-bicyclo(3.3.1)nonane-2,4-dione
C8H11N1O2
Crystal Growth & Design (2008) 8, 2 549
a=7.938(7)Å b=9.754(3)Å c=7.481(2)Å
α=90° β=97.03(6)° γ=90°
3-aza-bicyclo(3.3.1)nonane-2,4-dione
C8H11N1O2
Crystal Growth & Design (2008) 8, 2 549
a=8.054(7)Å b=9.782(3)Å c=7.5043(19)Å
α=90° β=96.80(5)° γ=90°
Pyrimethaminium+saccharinate+methanol
C12H14ClN41,C7H4NO3S1,CH4O
CrystEngComm (2013) 15, 15 2916
a=6.90400(10)Å b=7.58660(10)Å c=21.2823(3)Å
α=85.3640(10)° β=81.0520(10)° γ=79.0070(10)°
Salicylamide
C7H7N1O2
CrystEngComm (2010) 12, 4 1065
a=12.2791(7)Å b=4.7643(3)Å c=17.9649(17)Å
α=90° β=93.960(4)° γ=90°
S-4-Sulfo-L-Phenylalanine monohydrate
C9H13N1O6S1
Acta Crystallographica Section B (2009) 65, 6 731-748
a=6.4946(4)Å b=7.6198(3)Å c=11.5599(17)Å
α=90° β=93.306(7)° γ=90°
Bianthrone
C28H16O2
Acta Crystallographica Section B (2011) 67, 3 226-237
a=9.7119(14)Å b=7.041(2)Å c=11.2282(18)Å
α=90° β=110.229(10)° γ=90°
Salicylaldoxime
C7H7N1O2
Acta Crystallographica Section B (2006) 62, 6 1099-1111
a=9.5728(15)Å b=4.9342(3)Å c=11.7537(15)Å
α=90° β=110.064(10)° γ=90°
C11H15NO2
C11H15NO2
Inorganic Chemistry (2011) 50, 4515-4522
a=8.5221(4)Å b=10.7421(5)Å c=11.6515(6)Å
α=90.00° β=90.00° γ=90.00°
C15H23NO2
C15H23NO2
Inorganic Chemistry (2011) 50, 4515-4522
a=12.1513(3)Å b=8.1802(2)Å c=15.2351(4)Å
α=90.00° β=106.752(2)° γ=90.00°
C12H17NO3
C12H17NO3
Inorganic Chemistry (2011) 50, 4515-4522
a=9.6192(4)Å b=10.6124(4)Å c=11.8069(5)Å
α=90.00° β=90.00° γ=90.00°
C15H23N1O2
C15H23N1O2
Inorganic Chemistry (2011) 50, 4515-4522
a=12.5153(8)Å b=8.0997(5)Å c=14.0564(8)Å
α=90.00° β=96.496(4)° γ=90.00°
C7H6BrNO2
C7H6BrNO2
Inorganic Chemistry (2011) 50, 4515-4522
a=13.2519(4)Å b=3.96160(10)Å c=14.4954(5)Å
α=90.00° β=91.832(2)° γ=90.00°
C12H17NO2
C12H17NO2
Inorganic Chemistry (2011) 50, 4515-4522
a=9.4523(6)Å b=9.6626(5)Å c=25.5013(15)Å
α=90.00° β=90.00° γ=90.00°
C15H22N2O4
C15H22N2O4
Inorganic Chemistry (2011) 50, 4515-4522
a=7.0554(6)Å b=13.7741(13)Å c=8.3130(5)Å
α=91.144(6)° β=106.331(6)° γ=89.509(7)°
C66H84Cu3N6O12
C66H84Cu3N6O12
Inorganic Chemistry (2011) 50, 4515-4522
a=10.3884(5)Å b=10.3905(5)Å c=18.9956(9)Å
α=77.787(3)° β=83.298(3)° γ=60.492(2)°
C30H44CuN2O4
C30H44CuN2O4
Inorganic Chemistry (2011) 50, 4515-4522
a=31.7417(14)Å b=8.3449(4)Å c=16.3194(7)Å
α=90.00° β=90.035(3)° γ=90.00°
C24H32CuN2O4
C24H32CuN2O4
Inorganic Chemistry (2011) 50, 4515-4522
a=18.6883(2)Å b=18.6883Å c=13.3732(2)Å
α=90.00° β=90.00° γ=90.00°
C22H26Br2CuN2O4
C22H26Br2CuN2O4
Inorganic Chemistry (2011) 50, 4515-4522
a=5.8093(4)Å b=8.9279(6)Å c=12.0867(9)Å
α=71.499(5)° β=82.942(5)° γ=72.686(5)°
C24H32CuN2O6
C24H32CuN2O6
Inorganic Chemistry (2011) 50, 4515-4522
a=17.7657(9)Å b=20.8218(11)Å c=6.5914(4)Å
α=90.00° β=96.641(3)° γ=90.00°
C11H14ClNO2
C11H14ClNO2
Inorganic Chemistry (2011) 50, 4515-4522
a=13.5893(6)Å b=13.6734(6)Å c=25.0498(10)Å
α=89.985(3)° β=99.204(3)° γ=89.986(3)°
C11H14BrNO2
C11H14BrNO2
Inorganic Chemistry (2011) 50, 4515-4522
a=13.8459(4)Å b=13.9486(4)Å c=24.8103(7)Å
α=90.00° β=99.796(2)° γ=90.00°